Pharmacy Representation Review 2020 (Reforming LPCs and PSNC)

NPA brief guide to the EU Falsified Medicines Directive

A comprehensive resource in an FAQ format to help you understand the Falsified Medicines Directive, which comes into effect from March 29 2019.

What is it? The EU’s Falsified Medicines Directive – or FMD for short – aims to reduce the risk of counterfeit products entering the medicine supply chain. It comes into force on February 9th 2019. All prescription medicine packs produced after that date must have a tamper evident seal and unique code. Packs will display a 2D barcode (data matrix) which will incorporate the unique code, along with the product code, batch number and expiry date. What does it mean for pharmacies? FMD means pharmacies will have to check that the tamper evident seal is intact, and scan the barcode on every pack to confirm that its unique code is held in the national database. When do community pharmacies have to perform the checks? The directive requires the scanning and tamper evident seal checking to take place at the time of supply to the public. The NPA and other pharmacy organisations have produced guidance proposing that the check should take place at some point from when a pack is picked, to when the patient (or their representative) receives the pack. What sanctions regime is in place for FMD? The NPA and other pharmacy organisations are working with the Department of Health and Social Care, MHRA and the GPhC seeking to ensure that any sanction for non-compliance will be applied fairly and proportionately.…

The NPA challenges the government to meet its legal duty on health inequalities

The following is a brief guide to a Judicial Review currently being considered in the Court of Appeal. This guide was written in March 2017, ahead of a High Court hearing. An additional section has been added to summarise the NPA’s case in the Court of Appeal (heard 22-23 May 2018)

The following is a brief guide to a Judicial Review currently being considered in the Court of Appeal. This guide was written in March 2017, ahead of a High Court hearing. An additional section has been added to summarise the NPA’s case in the Court of Appeal (heard 22-23 May 2018) What is Judicial Review? Judicial review is the process whereby people affected by a decision the government has taken can ask the High Court to decide if the decision was lawfully made. If the court decides that the decision has been made unlawfully, the court is able to “quash” or reverse the decision, which means that the government either has to abandon its policy or retake the decision in a lawful way. Timeline In December 2016 the NPA issued judicial review proceedings against the Department of Health. The Pharmaceutical Services Negotiating Committee (PSNC) also issued judicial review proceedings around the same time. The PSNC is the body which is charged with formally negotiating with the Department of Health over pharmacy funding and PSNC has a right to be consulted by the Department of Health on any changes to the way in which pharmacies are paid for their services. PSNC’s case concerns faults they say occurred during the consultation period which it is said render the consultation and the decision unlawful.…

NPA Insurance Ltd Solvency and Financial Condition Report 2018

Solvency and Financial Condition Report for the year ending 31 December 2017.

Indemnity Insurance GDPR Policy

NPA Insurance Ltd is committed to protecting your personal information. This Privacy Policy relates to our use of any personal information we collect from you and others during the establishment, exercise or defence of legal claims, in accordance with GDPR 2018.

NPA Insurance Ltd is committed to protecting your personal information. This Privacy Policy relates to our use of any personal information we collect from you and others during the establishment, exercise or defence of legal claims, in accordance with GDPR 2018.…